Patents by Inventor Kenji Sampei

Kenji Sampei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of using selective parp inhibitors to prevent or treat neurotoxicity
    Patent number: 6358975
    Abstract: Neutral tissue damage resulting for ischemia and reperfusion injury or neurodegenerative diseases can be prevented by administering therapeutically effective amounts of certain selective inhibitors of poly(ADP-ribose)polymerase. The inhibitors can be administered intravenously, intraperitoneally, intramuscularly, intraventricularly, or orally. They can be administered as a capsule or tablet containing single or divided dose. Alternatively, the inhibitors can be administered as a sterile solution, suspension or emulsion.
    Type: Grant
    Filed: February 11, 2000
    Date of Patent: March 19, 2002
    Assignee: Johns Hopkins University
    Inventors: Mikael J. Eliasson, Kenji Sampei, Allen S. Mandir, Patricia D. Hurn, Richard J. Traystman, Jun Bao, Andrew Pieper, Ted M. Dawson, Solomon Snyder, Valina L. Dawson